2-Pfizer-3-4-21

 

Welcome to our virtual exhibit booth!

Pfizer logo


About Us

At Pfizer Oncology, we are committed to advancing medicines wherever we believe we can make a meaningful difference in the lives of people living with cancer. Today, we have an industry-leading portfolio of 23 approved innovative cancer medicines and biosimilars across more than 30 indications, including breast, genitourinary, colorectal, blood and lung cancers, as well as melanoma.

Click the graphic below for more information.

Pfizer Virtual Booth


Questions? Join us on Zoom at 7 pm

Topic: Ibrance/Talzenna/Trazimera


Contact Us

April Bryant
Oncology Account Specialist (Ibrance/Talzenna)
april.bryant@pfizer.com
(703) 304-7135

Heather Riley-Cline
Oncology Account Specialist (Trazimera)
heather.riley-cline@pfizer.com
(540) 931-2348
 

_____________________________________________